Literature DB >> 18930924

Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.

Nathan J Cobb1, Adrian C Apetri, Witold K Surewicz.   

Abstract

Transmissible spongiform encephalopathies are associated with conformational conversion of the cellular prion protein, PrP(C), into a proteinase K-resistant, amyloid-like aggregate, PrP(Sc). Although the structure of PrP(Sc) remains enigmatic, recent studies have afforded increasingly detailed characterization of recombinant PrP amyloid. However, all previous studies were performed using amyloid fibrils formed in the presence of denaturing agents that significantly alter the folding state(s) of the precursor monomer. Here we report that PrP amyloid can also be generated under physiologically relevant conditions, where the monomeric protein is natively folded. Remarkably, site-directed spin labeling studies reveal that these fibrils possess a beta-core structure nearly indistinguishable from that of amyloid grown under denaturing conditions, where the C-terminal alpha-helical domain of the PrP monomer undergoes major refolding to a parallel and in-register beta-structure upon conversion. The structural similarity of fibrils formed under drastically different conditions strongly suggests that the common beta-sheet architecture within the approximately 160-220 core region represents a distinct global minimum in the PrP conversion free energy landscape. We also show that the N-terminal region of fibrillar PrP displays conformational plasticity, undergoing a reversible structural transition with an apparent pK(a) of approximately 5.3. The C-terminal region, on the other hand, retains its beta-structure over the pH range 1-11, whereas more alkaline buffer conditions denature the fibrils into constituent PrP monomers. This profile of pH-dependent stability is reminiscent of the behavior of brain-derived PrP(Sc), suggesting a substantial degree of structural similarity within the beta-core region of these PrP aggregates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930924      PMCID: PMC2596397          DOI: 10.1074/jbc.M806701200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Evidence for synthesis of scrapie prion proteins in the endocytic pathway.

Authors:  D R Borchelt; A Taraboulos; S B Prusiner
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

2.  pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231).

Authors:  W Swietnicki; R Petersen; P Gambetti; W K Surewicz
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

3.  N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.

Authors:  B Caughey; G J Raymond; D Ernst; R E Race
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation.

Authors:  A Taraboulos; M Rogers; D R Borchelt; M P McKinley; M Scott; D Serban; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  NMR solution structure of the human prion protein.

Authors:  R Zahn; A Liu; T Lührs; R Riek; C von Schroetter; F López García; M Billeter; L Calzolai; G Wider; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).

Authors:  Olga V Bocharova; Leonid Breydo; Alexander S Parfenov; Vadim V Salnikov; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2004-12-19       Impact factor: 5.469

7.  NMR structure of the mouse prion protein domain PrP(121-231).

Authors:  R Riek; S Hornemann; G Wider; M Billeter; R Glockshuber; K Wüthrich
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

8.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.

Authors:  D G Donne; J H Viles; D Groth; I Mehlhorn; T L James; F E Cohen; S B Prusiner; P E Wright; H J Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

Review 9.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 10.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  25 in total

1.  Generation of prions in vitro and the protein-only hypothesis.

Authors:  Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  Prion       Date:  2010-04-05       Impact factor: 3.931

2.  Influence of pH on the human prion protein: insights into the early steps of misfolding.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

Review 3.  Prions and the potential transmissibility of protein misfolding diseases.

Authors:  Allison Kraus; Bradley R Groveman; Byron Caughey
Journal:  Annu Rev Microbiol       Date:  2013-06-28       Impact factor: 15.500

4.  Dissociation of recombinant prion protein fibrils into short protofilaments: implications for the endocytic pathway and involvement of the N-terminal domain.

Authors:  Xu Qi; Roger A Moore; Michele A McGuirl
Journal:  Biochemistry       Date:  2012-05-23       Impact factor: 3.162

5.  The intrinsic helical propensities of the helical fragments in prion protein under neutral and low pH conditions: a replica exchange molecular dynamics study.

Authors:  Xiaoliang Lu; Juan Zeng; Ya Gao; John Z H Zhang; Dawei Zhang; Ye Mei
Journal:  J Mol Model       Date:  2013-09-17       Impact factor: 1.810

6.  Differential stability of the bovine prion protein upon urea unfolding.

Authors:  Olivier Julien; Subhrangsu Chatterjee; Angela Thiessen; Steffen P Graether; Brian D Sykes
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

Review 7.  High-resolution structure of infectious prion protein: the final frontier.

Authors:  Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  Nat Struct Mol Biol       Date:  2012-04-04       Impact factor: 15.369

Review 8.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

Review 9.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

10.  Antimicrobial activity of human prion protein is mediated by its N-terminal region.

Authors:  Mukesh Pasupuleti; Markus Roupe; Victoria Rydengård; Krystyna Surewicz; Witold K Surewicz; Anna Chalupka; Martin Malmsten; Ole E Sörensen; Artur Schmidtchen
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.